A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

A First-in-Human Phase 1, Dose Escalation, Safety and Pharmacokinetic Study of PF-06647020 in Adult Patients With Advanced Solid Tumors

Category & Conditions:
Cancer
Medicine:
PF-06647020
ClinicalTrials.gov Identifier (NCT):
NCT02222922
Protocol ID:
B7661001
SharePrintDownload
Open Plain Language Summary Result:Click here